- Location
PreventIV
"-
Sagent Pharmaceuticals Launches Octreotide Acetate Injection,a Somatostatin Analog
Dec 26, 2013Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Octreotide Acetate Injection, a Somatostatin Analog, in five vial presentations. According to IMS, for the 12 months ending October 2013, the US market for Octreotide ...
-
US-Based Sagent Pharmaceuticals Has Introduced an Antineoplastic Agent
Nov 14, 2013US-based Sagent Pharmaceuticals has introduced an antineoplastic agent ' Doxorubicin Hydrochloride Injection' in three vial presentations. The injection has been used to produce regression in disseminated neoplastic conditions like acute ...
-
US-Based Sagent Pharmaceuticals Has Introduced an Antineoplastic Agent
Nov 8, 2013US-based Sagent Pharmaceuticals (SGNT) has introduced an antineoplastic agent 'Carboplatin Injection' in four preservative-free vial presentations. The injection is indicated for the initial treatment of advanced ovarian carcinoma in ...
-
SGNT Has Received The Approval of Zoledronic Acid Injection 4mg/100ml
Aug 9, 2013Sagent Pharma (SGNT) has received the approval of Zoledronic Acid Injection 4mg/100ml, the generic form of the bisphosphonate Zometa, to be packed in a ready-to-use premix IV bag. The new packaging for Zoledronic Acid Injection features ...
Tags: Sagent, Premix Bag, Zoledronic Acid
-
Sagent Has Re-Introduced an Antiarrhythmic Agent Amiodarone HCl Injection
Aug 7, 2013Sagent Pharmaceuticals has re-introduced an antiarrhythmic agent Amiodarone HCl Injection as an improved prefilled plastic syringe compatible with standard I.V. pumps. Featuring Sagent's PreventIV Measures packaging and labeling to help ...
Tags: HCL Injection, Health
-
Sagent Pharmaceuticals Has Introduced an Antineoplastic Agent
Aug 2, 2013Specialty pharmaceutical company Sagent Pharmaceuticals has introduced an antineoplastic agent, Docetaxel Injection Concentrate, in three preservative-free vial presentations. Designed to help reduce medication errors, the product ...
Tags: Sagent, Medicine errors
-
Sagent Pharmaceuticals Has Introduced Flumazenil Injection, USP
Jan 4, 2013Sagent Pharmaceuticals has introduced Flumazenil Injection, USP, available in two latex-free vials featuring the PreventIV Measures packaging and labeling. The benzodiazepine antagonist is indicated for the complete or partial reversal of ...
Tags: Sagent Pharmaceuticals, Flumazenil Injection, USP, PreventIV
-
The Package Insert Contains Detailed Information About The Indications
Dec 13, 2012Pharmaceutical company Sagent has announced the launch of Oxacillin for Injection, USP in three latex-free, preservative-free vial presentations. According to Sagent, the new Oxacillin features its PreventIV Measures packaging and ...
-
Nafcillin Is Unveiled by Sagent Pharmaceuticals for Injection
Dec 4, 2012Sagent Pharmaceuticals has launched Nafcillin for Injection, USP in two vial presentations and one pharmacy bulk package bottle, which are preservative-free and latex-free. Nafcillin had hit nearly $62m sales for 12 months ending ...
Tags: Nafcillin, injection, Sagent Pharmaceuticals, suspected cases
-
Sagent Pharmaceuticals Has Introduced Acetazolamide for Injection
Nov 28, 2012Sagent Pharmaceuticals has introduced Acetazolamide for Injection, USP specified for adjunctive treatment of edema due to congestive heart failure, drug-induced edema, centrencephalic epilepsies and chronic simple glaucoma, secondary ...
Tags: Acetazolamide Injection, adjunctive treatment, Pharmaceuticals
-
Sagent Has Introduced Irinotecan Injection in Single Dose Vials
Nov 28, 2012Sagent Pharmaceuticals, a specialty pharmaceutical company, has introduced Irinotecan injection in two latex free, preservative free single dose vials. The antineoplastic agent of the topoisomerase I inhibitor class, in combination with ...
-
Sagent Pharmaceuticals Has Introduced a Folic Acid Derivative Therapy
Nov 28, 2012Sagent Pharmaceuticals has introduced a folic acid derivative therapy, designed to treat megaloblastic anemias patients who are not responding to oral therapy. The new Leucovorin Calcium for Injection is indicated for rescue after ...
-
Sagent Pharmaceuticals Has Launched Ondansetron Injection,USP,an Antiemetic
Nov 28, 2012Sagent Pharmaceuticals,a specialty pharmaceutical company,has launched Ondansetron Injection,USP,an antiemetic,in two latex-free vial presentations. Ondansetron Injection,USP is indicated for prevention of nausea and vomiting associated ...
-
Sagent Has Launched Apnea of Prematurity Drug in Two Latex-Free Vial Presentations
Oct 4, 2012Sagent Pharmaceuticals has launched Caffeine Citrate Injection, USP and Caffeine Citrate Oral Solution, USP, central nervous system stimulants, in two latex-free vial presentations. Caffeine Citrate Injection, USP and Caffeine Citrate ...
Tags: Drug, Medicine, Sagent Pharmaceuticals
-
Sagent Pharmaceuticals has launched Vancomycin Hydrochloride for injection
Oct 1, 2012Sagent Pharmaceuticals has launched Vancomycin Hydrochloride for injection, USP, an anti-infective, in a 5gm pharmacy bulk package mode. Vancomycin is designed to help reduce medication errors and features the company's PreventIV Measures ...
Tags: Medicine, Vancomycin
